Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 11 Precancerous Conditions 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Male Urogenital Diseases 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Non-melanoma Skin Cancer 1 Neoplasms 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Risk 1 Arsenic Poisoning 1 Adenomatous Polyps 1

Interventions

Gemcitabine 78 Cisplatin 55 pembrolizumab 31 Paclitaxel 28 Carboplatin 24 Docetaxel 19 Radiotherapy 17 Mitomycin 16 Doxorubicin 15 atezolizumab 14 BCG Vaccine 14 Nivolumab 13 Cystectomy 12 Filgrastim 11 vinflunine 10 Methotrexate 10 Vinblastine 9 Fluorouracil 9 5-aminolevulinic acid hexyl ester 9 Sunitinib 7 Early Intervention, Educational 7 durvalumab 6 avelumab 6 Taxes 6 Methods 6 Cystoscopy 6 Albumin-Bound Paclitaxel 6 enfortumab vedotin 5 Trastuzumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urinary Bladder Neoplasms × Selenium × Clear all

NCT00729287 2016-05-12

SELEBLAT

KU Leuven

Phase 3 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡